Pablo Tebas

Pablo Tebas

University of Pennsylvania

H-index: 81

North America-United States

About Pablo Tebas

Pablo Tebas, With an exceptional h-index of 81 and a recent h-index of 45 (since 2020), a distinguished researcher at University of Pennsylvania, specializes in the field of Infectious Diseases.

His recent articles reflect a diverse array of research interests and contributions to the field:

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy

CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication

Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells

Combination of Extended Antivirals With Antiretrovirals for Severe Mpox in Advanced Human Immunodeficiency Virus Infection: Case Series of 4 Patients

Cognate Antigen Engagement Induces HIV-1 Expression In CD4+ T Cells From People On Long-Term ART

Pablo Tebas Information

University

Position

___

Citations(all)

23135

Citations(since 2020)

7862

Cited By

17705

hIndex(all)

81

hIndex(since 2020)

45

i10Index(all)

215

i10Index(since 2020)

141

Email

University Profile Page

University of Pennsylvania

Google Scholar

View Google Scholar Profile

Pablo Tebas Skills & Research Interests

Infectious Diseases

Top articles of Pablo Tebas

Title

Journal

Author(s)

Publication Date

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

EClinicalMedicine

Ilias I Siempos

Andre C Kalil

Drifa Belhadi

Viviane Cordeiro Veiga

Alexandre Biasi Cavalcanti

...

2024/3/1

Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial

JAMA cardiology

Michael T Lu

Heather Ribaudo

Borek Foldyna

Markella V Zanni

Thomas Mayrhofer

...

2024/2/21

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

The Lancet HIV

Chloe Orkin

Jean-Michel Molina

Pedro Cahn

Johannes Lombaard

Khuanchai Supparatpinyo

...

2024/2/1

The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy

AIDS

Jeffrey M Jacobson

Barbara K Felber

Huichao Chen

George N Pavlakis

James I Mullins

...

2022/4/20

CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication

The Journal of clinical investigation

Pablo Tebas

Julie K Jadlowsky

Pamela A Shaw

Lifeng Tian

Erin Esparza

...

2021/4/1

Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells

Nature Immunology

Nathan L Board

Zhe Yuan

Fengting Wu

Milica Moskovljevic

Meghana Ravi

...

2024/1/26

Combination of Extended Antivirals With Antiretrovirals for Severe Mpox in Advanced Human Immunodeficiency Virus Infection: Case Series of 4 Patients

Open Forum Infectious Diseases

Michael T Duong

Pablo Tebas

Bhavya Ancha

Jillian Baron

Pallavi Chary

...

2024/2/27

Cognate Antigen Engagement Induces HIV-1 Expression In CD4+ T Cells From People On Long-Term ART

bioRxiv

Milica Moskovjlevic

Filippo Dragoni

Nathan L Board

Fengting Wu

Jun Lai

...

2024

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

EClinicalMedicine

Prasanna Jagannathan

Kara W Chew

Mark J Giganti

Michael D Hughes

Carlee Moser

...

2023/11/1

A prospective 18F-FDG PET/CT study of the neurometabolic effects in cocaine use and HIV infection.

AIDS (London, England)

Ramya S Mamidi

Cyrus Ayubcha

Grant Rigney

Jason Kirschner

Oke Gerke

...

2023/1/20

Susceptibility to 3BNC117 and 10-1074 in ART suppressed chronically infected persons

AIDS

Pablo Tebas

Kenn Lynn

Livio Azzoni

Giorgio Cocchella

Emmanouil Papasavvas

...

2023/7/1

Susceptibility to anti-HIV bnAbs is concordant in pre-ART plasma and on-ART PBMC samples: ACTG NWCS413

Conference for Retroviruses and Opportunistic Infections. Seattle, WA, USA2019

Jacqueline Reeves

Yu Zheng

Maxine Olefsky

Yolanda Lie

Leah Burke

...

2023

Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States

HIV Research & Clinical Practice

Andrea Bilger

Eion Plenn

Frances K Barg

Katharine A Rendle

William B Carter

...

2023/10/6

Phenotypic analysis of HIV-1 resistance to CD4 binding site broadly-neutralizing antibodies

The Journal of Immunology

Hannah Shrader

Sabrina Helmold Hait

Sarah Lovelace

Meaghan Kilner

Chen-Hsiang Shen

...

2023/5/1

The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy

The Journal of Clinical Investigation

Natalie F McMyn

Joseph Varriale

Emily J Fray

Carolin Zitzmann

Hannah MacLeod

...

2023/9/1

A prospective 18F-fluorodeoxyglucose positron emission tomography/computed tomography study of the neurometabolic effects in cocaine use and HIV infection

AIDS

Ramya S Mamidi

Cyrus Ayubcha

Grant Rigney

Jason Kirschner

Oke Gerke

...

2023/5/1

The Penn Medicine COVID-19 Therapeutics Committee—Reflections on a model for rapid evidence review and dynamic practice recommendations during a public health emergency

George L Anesi

Kathleen Degnan

Lauren Dutcher

Stephen Saw

Christina Maguire

...

2023/8

Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir

Nature Immunology

Vincent H Wu

Jayme ML Nordin

Son Nguyen

Jaimy Joy

Felicity Mampe

...

2023/2

Cytomegalovirus immunoglobulin G (IgG) titer and coronary artery disease in people with human immunodeficiency virus (HIV)

Clinical Infectious Diseases

Samuel R Schnittman

Michael T Lu

Thomas Mayrhofer

Tricia H Burdo

Kathleen V Fitch

...

2023/2/1

“I know that I was a part of making a difference”: Participant motivations for joining a cure-directed HIV trial with an analytical treatment interruption

AIDS Research and Human Retroviruses

Rebecca Neergaard

Nora L Jones

Christopher Roebuck

Katharine A Rendle

Zoe Barbati

...

2023/8/1

See List of Professors in Pablo Tebas University(University of Pennsylvania)

Co-Authors

H-index: 79
Robert A. Parker

Robert A. Parker

Harvard University

H-index: 58
Susan Swindells

Susan Swindells

University of Nebraska Medical Center

H-index: 45
Vincent Lo Re III, MD, MSCE

Vincent Lo Re III, MD, MSCE

University of Pennsylvania

H-index: 24
Doug Kitch

Doug Kitch

Harvard University

academic-engine